Eculizumab for Pediatric Hematopoietic Cell Transplant–Associated Thrombotic Microangiopathy: Real-World Response Rates, Predictors of Poor Response, and an Optimal Time Point for Treatment Response Assessment

Transplantation and Cellular Therapy 2026

View at publisher
Authors: Michelle Long Schoettler, Geoffrey Cheng, Christine S. Higham, Christopher C. Dvorak, Cassandra Rush, Hemalatha G. Rangarajan, Majed W. Al-Nazer, Veronika Polishchuk, Sonali Chaudhury, Leslie Lehmann, Christine Duncan, Miki Nishitani
+12 more Haig Manougian, Seth Rotz, Joel Ofori, Erin Frost, Jeremy Orbodo, Kathleen Spencer, Ellen Kenney, Satheesh Chonat, Joseph H. Chewning, Caitlin Moore, Adrianna Lynn Westbrook, Kirsten M Williams
DOI: 10.1016/j.jtct.2026.04.026
Cited by: 1
References: 41

Fields of Study & Subjects

Complement system in diseases Renal Diseases and Glomerulopathies Coagulation Bradykinin Polyphosphates and Angioedema

Publication details

Journal / source
Transplantation and Cellular Therapy
Publisher
Elsevier BV
Volume
32
Issue
7
Pages
887.e1–887.e16
Publication date
24 April 2026
Language
EN